Shanghai Pharmaceuticals Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SZSC:2607 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
07 Nov 24	BuyHK$5,135,719	Shanghai Industrial Investment (Holding) Co., Ltd.	Company	400,000	HK$12.84
04 Jun 24	SellHK$53,587,076	BlackRock, Inc.	Company	4,597,263	HK$11.66
24 Jan 24	SellHK$6,082,458	BlackRock, Inc.	Company	575,500	HK$10.57

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2607?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	134,709	0.00364%
Institutions	524,788,759	14.2%
Public Companies	665,626,796	18%
Private Companies	1,213,540,637	32.8%
General Public	1,300,519,957	35.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 61.13% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.3%	SIIC Shanghai (Holdings) Corporation Limited	716,516,039	HK$14.6b	0%	no data
18%	Yunnan Baiyao Group Co.,Ltd	665,626,796	HK$13.6b	0%	no data
12.2%	Shanghai Industrial Investment (Holding) Co., Ltd.	452,392,498	HK$9.2b	1.39%	no data
1.31%	BlackRock, Inc.	48,356,355	HK$986.1m	-5.83%	no data
1.2%	Shanghai Guosheng Group Co., Ltd.	44,632,100	HK$910.1m	0%	1.75%
1.2%	Shanghai Shengrui Investment Co., Ltd.	44,632,100	HK$910.1m	0%	no data
1.15%	The Vanguard Group, Inc.	42,490,929	HK$866.5m	0.58%	no data
1.12%	China Securities Finance Corp, Asset Management Arm	41,330,543	HK$842.8m	0%	0.14%
0.5%	E Fund Management Co., Ltd.	18,495,530	HK$377.2m	0%	0.06%
0.47%	New China Life Insurance Co., Ltd., Asset Management Arm	17,512,196	HK$357.1m	0%	2.09%
0.45%	GF Fund Management Co., Ltd.	16,737,106	HK$341.3m	0%	0.07%
0.45%	China Construction Bank Corporation, Asset Management Arm	16,734,637	HK$341.2m	0%	1.89%
0.43%	Dimensional Fund Advisors LP	15,798,807	HK$322.2m	0.23%	no data
0.41%	Qian Hai Life Insurance Co., Ltd., Asset Management Arm	15,136,400	HK$308.7m	0%	4.51%
0.36%	Bosera Asset Management Co., Ltd.	13,514,000	HK$275.6m	0%	0.11%
0.32%	Yinhua Fund Management Co., Ltd.	11,962,722	HK$243.9m	0%	0.21%
0.3%	China Universal Asset Management Company Ltd.	11,182,571	HK$228.0m	0%	0.1%
0.27%	ICBC Credit Suisse Asset Management Co., Ltd.	10,169,266	HK$207.4m	0%	0.15%
0.27%	China Asset Management Co. Ltd.	10,089,285	HK$205.7m	-0.02%	0.02%
0.27%	Harvest Fund Management Co. Ltd.	9,992,387	HK$203.8m	0%	0.06%
0.26%	Dacheng Fund Management Co., Ltd.	9,715,325	HK$198.1m	0%	0.18%
0.25%	Huatai-PineBridge Fund Management Co., Ltd.	9,114,312	HK$185.9m	0%	0.06%
0.24%	Norges Bank Investment Management	8,736,519	HK$178.2m	0%	no data
0.2%	Fullgoal Fund Management Co. Ltd.	7,581,701	HK$154.6m	0%	0.06%
0.16%	Swedbank Robur Fonder AB	5,995,218	HK$122.3m	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 13:40
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Pharmaceuticals Holding Co., Ltd is covered by 52 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Xing Qiu Lin	AJ Securities Co., Ltd
Zhi Xue Diao	Avic Securities Co., Ltd
Derrick Sun	BNP Paribas Securities (Asia)